A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
Clinical trial NCT06864143 · COMPLETED
Trial details
- NCT number
- NCT06864143
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-07
- Primary completion
- 2025-10-13
- Enrollment
- 1320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.